172 related articles for article (PubMed ID: 27129274)
1. Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies.
Blanchetot C; De Jonge N; Desmyter A; Ongenae N; Hofman E; Klarenbeek A; Sadi A; Hultberg A; Kretz-Rommel A; Spinelli S; Loris R; Cambillau C; de Haard H
J Biol Chem; 2016 Jun; 291(26):13846-54. PubMed ID: 27129274
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies.
Kalai M; Montero-Julian FA; Brakenhoff JP; Fontaine V; De Wit L; Wollmer A; Brailly H; Content J; Grötzinger J
Eur J Biochem; 1997 Nov; 249(3):690-700. PubMed ID: 9395315
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
4. Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling.
Shaw S; Bourne T; Meier C; Carrington B; Gelinas R; Henry A; Popplewell A; Adams R; Baker T; Rapecki S; Marshall D; Moore A; Neale H; Lawson A
MAbs; 2014; 6(3):774-82. PubMed ID: 24670876
[TBL] [Abstract][Full Text] [Related]
5. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.
Argiriadi MA; Xiang T; Wu C; Ghayur T; Borhani DW
J Biol Chem; 2009 Sep; 284(36):24478-89. PubMed ID: 19553661
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 as a key player in systemic inflammation and joint destruction.
Fonseca JE; Santos MJ; Canhão H; Choy E
Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody.
Beyer BM; Ingram R; Ramanathan L; Reichert P; Le HV; Madison V; Orth P
J Mol Biol; 2008 Oct; 382(4):942-55. PubMed ID: 18708069
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics analysis of the binding of human interleukin-6 with interleukin-6 α-receptor.
Gupta M; Ha K; Agarwal R; Quarles LD; Smith JC
Proteins; 2021 Feb; 89(2):163-173. PubMed ID: 32881084
[TBL] [Abstract][Full Text] [Related]
9. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M
Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668
[TBL] [Abstract][Full Text] [Related]
10. Functional implications of large backbone amplitude motions of the glycoprotein 130-binding epitope of interleukin-6.
Bobby R; Robustelli P; Kralicek AV; Mobli M; King GF; Grötzinger J; Dingley AJ
FEBS J; 2014 May; 281(10):2471-83. PubMed ID: 24712547
[TBL] [Abstract][Full Text] [Related]
11. Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.
Redpath NT; Xu Y; Wilson NJ; Fabri LJ; Baca M; Andrews AE; Braley H; Lu P; Ireland C; Ernst RE; Woods A; Forrest G; An Z; Zaller DM; Strohl WR; Luo CS; Czabotar PE; Garrett TP; Hilton DJ; Nash AD; Zhang JG; Nicola NA
Biochem J; 2013 Apr; 451(2):165-75. PubMed ID: 23384096
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.
Ranganath S; Bhandari A; Avitahl-Curtis N; McMahon J; Wachtel D; Zhang J; Leitheiser C; Bernier SG; Liu G; Tran TT; Celino H; Tobin J; Jung J; Zhao H; Glen KE; Graul C; Griffin A; Schairer WC; Higgins C; Reza TL; Mowe E; Rivers S; Scott S; Monreal A; Shea C; Bourne G; Coons C; Smith A; Tang K; Mandyam RA; Masferrer J; Liu D; Patel DV; Fretzen A; Murphy CA; Milne GT; Smythe ML; Carlson KE
PLoS One; 2015; 10(11):e0141330. PubMed ID: 26555695
[TBL] [Abstract][Full Text] [Related]
13. Structure of the extracellular domains of the human interleukin-6 receptor alpha -chain.
Varghese JN; Moritz RL; Lou MZ; Van Donkelaar A; Ji H; Ivancic N; Branson KM; Hall NE; Simpson RJ
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15959-64. PubMed ID: 12461182
[TBL] [Abstract][Full Text] [Related]
14. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
15. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S
Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991
[TBL] [Abstract][Full Text] [Related]
16. The solution structure of the membrane-proximal cytokine receptor domain of the human interleukin-6 receptor.
Hecht O; Dingley AJ; Schwanter A; Ozbek S; Rose-John S; Grötzinger J
Biol Chem; 2006 Sep; 387(9):1255-9. PubMed ID: 16972794
[TBL] [Abstract][Full Text] [Related]
17. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
[TBL] [Abstract][Full Text] [Related]
18. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition.
Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S
J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of Sant7 and anti-IL-6, IL-6R monoclonal antibodies in a murine model of B-cell lymphoma.
Campo S; Serlupi-Crescenzi O; Arseni B; Rossi S; Saggio I; Salone B; Cherubini G; Carminati P; De Santis R
Cytokine; 2005 Sep; 31(5):368-74. PubMed ID: 16061391
[TBL] [Abstract][Full Text] [Related]
20. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
